The hCA inhibition activity was measured on four different hCA isoforms: the cytosolic hCA I and hCA II, and the tumor-associated transmembrane hCA IX and hCA XII isoforms, to evaluate their hCA selectivity profiles. Here, CYP24A1 is linked to neoplasm.